MCID: ADR040
MIFTS: 46

Adrenal Gland Pheochromocytoma

Categories: Cancer diseases, Endocrine diseases

Aliases & Classifications for Adrenal Gland Pheochromocytoma

MalaCards integrated aliases for Adrenal Gland Pheochromocytoma:

Name: Adrenal Gland Pheochromocytoma 12 15 17
Pheochromocytoma 71

Classifications:



External Ids:

Disease Ontology 12 DOID:0050892
UMLS 71 C0031511

Summaries for Adrenal Gland Pheochromocytoma

Disease Ontology : 12 A malignant pheochromocytoma that is characterized by overproduction of adrenaline.

MalaCards based summary : Adrenal Gland Pheochromocytoma, also known as pheochromocytoma, is related to malignant pediatric adrenal gland pheochromocytoma and pheochromocytoma, and has symptoms including fever, tremor and abdominal pain. An important gene associated with Adrenal Gland Pheochromocytoma is NGF (Nerve Growth Factor), and among its related pathways/superpathways is Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways. The drugs Angiotensin II and Bromocriptine have been mentioned in the context of this disorder. Affiliated tissues include thyroid, adrenal gland and testes.

Related Diseases for Adrenal Gland Pheochromocytoma

Graphical network of the top 20 diseases related to Adrenal Gland Pheochromocytoma:



Diseases related to Adrenal Gland Pheochromocytoma

Symptoms & Phenotypes for Adrenal Gland Pheochromocytoma

UMLS symptoms related to Adrenal Gland Pheochromocytoma:


fever, tremor, abdominal pain, chest pain, headache

Drugs & Therapeutics for Adrenal Gland Pheochromocytoma

Drugs for Adrenal Gland Pheochromocytoma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 200, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Angiotensin II Approved, Investigational Phase 4 4474-91-3, 11128-99-7, 68521-88-0 172198
2
Bromocriptine Approved, Investigational Phase 4 25614-03-3 31101
3
Hydrochlorothiazide Approved, Vet_approved Phase 4 58-93-5 3639
4
Telmisartan Approved, Investigational Phase 4 144701-48-4 65999
5
Nebivolol Approved, Investigational Phase 4 99200-09-6, 118457-14-0, 152520-56-4 71301
6
Doxazosin Approved Phase 4 74191-85-8 3157
7
Levomilnacipran Approved, Investigational Phase 4 96847-54-0
8
Milnacipran Approved, Investigational Phase 4 92623-85-3 65833
9 Adrenergic beta-Agonists Phase 4
10 Adrenergic Agents Phase 4
11 Adrenergic Agonists Phase 4
12 Neurotransmitter Agents Phase 4
13 Antihypertensive Agents Phase 4
14 Vasodilator Agents Phase 4
15 Angiotensinogen Phase 4
16 Angiotensin Receptor Antagonists Phase 4
17 Giapreza Phase 4
18 Dopamine agonists Phase 4
19 Antiparkinson Agents Phase 4
20 Angiotensin II Type 1 Receptor Blockers Phase 4
21 Antidepressive Agents Phase 4
22 Psychotropic Drugs Phase 4
23 Serotonin and Noradrenaline Reuptake Inhibitors Phase 4
24 Duloxetine Hydrochloride Phase 4
25 Serotonin Uptake Inhibitors Phase 4
26
Serotonin Investigational, Nutraceutical Phase 4 50-67-9 5202
27
Tyramine Investigational, Nutraceutical Phase 4 51-67-2 5610
28
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
29
Lenograstim Approved, Investigational Phase 3 135968-09-1
30
Ifosfamide Approved Phase 3 3778-73-2 3690
31
Dexmedetomidine Approved, Vet_approved Phase 3 113775-47-6 5311068 68602
32
Magnesium Sulfate Approved, Investigational, Vet_approved Phase 3 7487-88-9 24083
33 Calamus Phase 3
34
Liposomal doxorubicin Phase 3 31703
35
Isophosphamide mustard Phase 3 0
36 Anti-Bacterial Agents Phase 3
37 Antibiotics, Antitubercular Phase 3
38 Pharmaceutical Solutions Phase 3
39 Analgesics, Non-Narcotic Phase 3
40 Anesthetics, General Phase 3
41 Hypnotics and Sedatives Phase 3
42 Anti-Arrhythmia Agents Phase 3
43 Anticonvulsants Phase 3
44
Indinavir Approved Phase 2 150378-17-9 5362440
45
Ritonavir Approved, Investigational Phase 2 155213-67-5 392622
46
Methylprednisolone Approved, Vet_approved Phase 2 83-43-2 6741
47
Prednisolone phosphate Approved, Vet_approved Phase 2 302-25-0
48
Methylprednisolone hemisuccinate Approved Phase 2 2921-57-5
49
Carbidopa Approved Phase 2 28860-95-9 34359
50 Prednisolone acetate Approved, Vet_approved Phase 2 52-21-1
51
Prednisolone Approved, Vet_approved Phase 2 50-24-8 5755
52
Everolimus Approved Phase 2 159351-69-6 70789204 6442177
53
Cisplatin Approved Phase 2 15663-27-1 2767 441203 84093
54
Sodium citrate Approved, Investigational Phase 2 68-04-2
55
Tamoxifen Approved Phase 2 10540-29-1 2733526
56
Melphalan Approved Phase 2 148-82-3 460612 4053
57
Pancrelipase Approved, Investigational Phase 2 53608-75-6
58
Somatostatin Approved, Investigational Phase 2 38916-34-6, 51110-01-1 53481605
59
Propranolol Approved, Investigational Phase 2 525-66-6 4946
60
Ramipril Approved Phase 2 87333-19-5 5362129
61
Candesartan cilexetil Approved Phase 2 145040-37-5 2540
62
Atenolol Approved Phase 2 29122-68-7 2249
63
Bisoprolol Approved Phase 2 66722-44-9 2405
64
Prazosin Approved Phase 2 19216-56-9 4893
65
Lidocaine Approved, Vet_approved Phase 2 137-58-6 3676
66
Pembrolizumab Approved Phase 2 1374853-91-4
67
Ipilimumab Approved Phase 2 477202-00-9
68
Lenvatinib Approved, Investigational Phase 2 417716-92-8
69
Sunitinib Approved, Investigational Phase 2 557795-19-4, 341031-54-7 5329102
70
Axitinib Approved, Investigational Phase 2 319460-85-0 6450551
71
Olaparib Approved Phase 2 763113-22-0 23725625
72
Parathyroid hormone Approved, Investigational Phase 2 9002-64-6
73
nivolumab Approved Phase 1, Phase 2 946414-94-4
74
lanreotide Approved Phase 2 108736-35-2
75
Atezolizumab Approved, Investigational Phase 2 1380723-44-3
76
Octreotide Approved, Investigational Phase 2 83150-76-9 383414 6400441
77
Tretinoin Approved, Investigational, Nutraceutical Phase 2 302-79-4 444795 5538
78
Citric acid Approved, Nutraceutical, Vet_approved Phase 2 77-92-9 311
79
Prednisolone hemisuccinate Experimental Phase 2 2920-86-7
80 Guadecitabine Investigational Phase 2 929901-49-5
81
Candesartan Experimental Phase 2 139481-59-7 2541
82
tipifarnib Investigational Phase 2 192185-72-1 159324
83 Pancreatic Polypeptide Investigational Phase 2 59763-91-6
84 Anti-Infective Agents Phase 2
85 Antiviral Agents Phase 2
86 Cytochrome P-450 Enzyme Inhibitors Phase 2
87
protease inhibitors Phase 2
88 Anti-HIV Agents Phase 2
89 HIV Protease Inhibitors Phase 2
90 Anti-Retroviral Agents Phase 2
91 Cytochrome P-450 CYP3A Inhibitors Phase 2
92 Methylprednisolone Acetate Phase 2
93 alpha-Methyltyrosine Phase 2
94 Immunosuppressive Agents Phase 2
95 Immunologic Factors Phase 2
96 Cola Phase 2
97 Citrate Phase 2
98 Estrogen Receptor Modulators Phase 2
99 Estrogen Antagonists Phase 2
100 Estrogens Phase 2
101 Estrogen Receptor Antagonists Phase 2
102 pancreatin Phase 2
103
Erlotinib Hydrochloride Phase 2 183319-69-9 176871
104 Angiotensin-Converting Enzyme Inhibitors Phase 2
105 Fluorodeoxyglucose F18 Phase 2
106 Antineoplastic Agents, Immunological Phase 2
107 Sodium Channel Blockers Phase 2
108 Diuretics, Potassium Sparing Phase 2
109 Anesthetics, Local Phase 2
110 Immunoglobulins Phase 2
111 Antibodies Phase 2
112 Antibodies, Monoclonal Phase 2
113 Protein Kinase Inhibitors Phase 2
114 Angiogenesis Inhibitors Phase 2
115 Vaccines Phase 1, Phase 2
116 Angiopeptin Phase 2
117 Edotreotide Phase 2
118 Antineoplastic Agents, Hormonal Phase 2
119 Gastrointestinal Agents Phase 2
120 Liver Extracts Phase 2
121
Levoleucovorin Approved, Investigational Phase 1 68538-85-2
122
leucovorin Approved Phase 1 58-05-9 6006 143
123
Floxuridine Approved Phase 1 50-91-9 5790
124
Oxaliplatin Approved, Investigational Phase 1 61825-94-3 43805 6857599 5310940 9887054
125
Vinorelbine Approved, Investigational Phase 1 71486-22-1 60780 44424639
126
Clotrimazole Approved, Vet_approved Phase 1 23593-75-1 2812
127
Miconazole Approved, Investigational, Vet_approved Phase 1 22916-47-8 4189
128
Sirolimus Approved, Investigational Phase 1 53123-88-9 5284616 6436030 46835353
129
Levodopa Approved Phase 1 59-92-7 6047
130
Folic acid Approved, Nutraceutical, Vet_approved Phase 1 59-30-3 6037
131
Phenylalanine Approved, Investigational, Nutraceutical Phase 1 63-91-2 6140
132
Vatalanib Investigational Phase 1 212141-54-3 151194
133 Vitamins Phase 1
134 Antidotes Phase 1
135 Vitamin B Complex Phase 1
136 Folate Phase 1
137 Vitamin B9 Phase 1
138 Protective Agents Phase 1
139 Antifungal Agents Phase 1
140 Tubulin Modulators Phase 1
141 Antimitotic Agents Phase 1
142 Interferon-beta Phase 1
143 interferons Phase 1
144
Metoclopramide Approved, Investigational 364-62-5 4168
145
Estradiol Approved, Investigational, Vet_approved 50-28-2 5757
146
Polyestradiol phosphate Approved 28014-46-2
147
Etodolac Approved, Investigational, Vet_approved 41340-25-4 3308
148
Glucagon Approved 16941-32-5
149
Bevacizumab Approved, Investigational 216974-75-3
150
Ethanol Approved 64-17-5 702
151
tannic acid Approved 1401-55-4
152
Benzocaine Approved, Investigational 94-09-7, 1994-09-7 2337
153
Remifentanil Approved 132875-61-7 60815
154
Propofol Approved, Investigational, Vet_approved 2078-54-8 4943
155
Testosterone Approved, Experimental, Investigational 58-22-0, 481-30-1 10204 6013
156
Dopamine Approved 51-61-6, 62-31-7 681
157
Hydrocortisone acetate Approved, Vet_approved 50-03-3
158
Hydrocortisone Approved, Vet_approved 50-23-7 5754
159
Dexamethasone acetate Approved, Investigational, Vet_approved 1177-87-3
160
Dexamethasone Approved, Investigational, Vet_approved 50-02-2 5743
161
Epinephrine Approved, Vet_approved 51-43-4 5816